We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Boeing Secures Order for 8 Dreamliners From Air New Zealand
Read MoreHide Full Article
The Boeing Company (BA - Free Report) has announced that it received an order for eight 787-10 airplane from Air New Zealand — the flagship carrier of the nation. The list price of the planes was $2.7 billion but the carrier was able to get a discount, which is quite common for bulk orders.
Air New Zealand will take delivery of the new 787-10 planes over a five-year period, beginning 2022. These fuel-efficient planes will be utilized by the carrier to gradually replace its fleet of eight Boeing 777-200.
Details of Boeing 787-10
The 787 Dreamliner is admired for the comfort and fuel efficiency compared to the planes of the same class. The 787-10 planes will have the ability to fly 6,430 miles and carry 330 passengers. These planes use engines either made by General Electric Company (GE - Free Report) or Rolls Royce. Air New Zealand opted for the Boston-based GE engines for its new planes.
The addition of 787-10 will be profitable to the carrier as it will be 25% more fuel efficient than the earlier versions.
Tough Times for Boeing
As of Apr 30, 2019, Boeing’s 2019 net orders were a negative 119, primarily due to adoption of new revenue recognition accounting standard (ASC 606) and drop in Boeing 737 orders. Taking into consideration the new accounting standard, the net order for 787 model was 28 at the end of April. The new orders for the 787 model are a welcome change for this commercial airplane manufacturer.
Boeing delivered 23 planes in April 2019 compared with 44 planes a year ago while Airbus Group SE (EADSY - Free Report) delivered 70 and 51 commercial jets, respectively. Boeing’s deliveries have been severely affected following the crash of Ethiopian Airlines Flight and grounding of 737 Max fleet by the carriers across the globe.
The 737 Max model is expected to fly post the confirmation and satisfaction of Aviation regulators from around the world.
Price Performance
Since the crash of 737 Max on Mar 10, 2019, shares of Boeing have declined wider than its industry’s fall.
Lockheed Martin delivered a positive earnings surprise in last four reported quarter, the average beat being 17.35%. The Zacks Consensus Estimate for 2019 has moved up 5.4% over the past 60 days to $20.53.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Boeing Secures Order for 8 Dreamliners From Air New Zealand
The Boeing Company (BA - Free Report) has announced that it received an order for eight 787-10 airplane from Air New Zealand — the flagship carrier of the nation. The list price of the planes was $2.7 billion but the carrier was able to get a discount, which is quite common for bulk orders.
Air New Zealand will take delivery of the new 787-10 planes over a five-year period, beginning 2022. These fuel-efficient planes will be utilized by the carrier to gradually replace its fleet of eight Boeing 777-200.
Details of Boeing 787-10
The 787 Dreamliner is admired for the comfort and fuel efficiency compared to the planes of the same class. The 787-10 planes will have the ability to fly 6,430 miles and carry 330 passengers. These planes use engines either made by General Electric Company (GE - Free Report) or Rolls Royce. Air New Zealand opted for the Boston-based GE engines for its new planes.
The addition of 787-10 will be profitable to the carrier as it will be 25% more fuel efficient than the earlier versions.
Tough Times for Boeing
As of Apr 30, 2019, Boeing’s 2019 net orders were a negative 119, primarily due to adoption of new revenue recognition accounting standard (ASC 606) and drop in Boeing 737 orders. Taking into consideration the new accounting standard, the net order for 787 model was 28 at the end of April. The new orders for the 787 model are a welcome change for this commercial airplane manufacturer.
Boeing delivered 23 planes in April 2019 compared with 44 planes a year ago while Airbus Group SE (EADSY - Free Report) delivered 70 and 51 commercial jets, respectively. Boeing’s deliveries have been severely affected following the crash of Ethiopian Airlines Flight and grounding of 737 Max fleet by the carriers across the globe.
The 737 Max model is expected to fly post the confirmation and satisfaction of Aviation regulators from around the world.
Price Performance
Since the crash of 737 Max on Mar 10, 2019, shares of Boeing have declined wider than its industry’s fall.
Zacks Rank & A Key Pick
Boeing currently has a Zacks Rank #3 (Hold). A better-ranked stock in the same industry worth considering is Lockheed Martin Corporation (LMT - Free Report) having a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Lockheed Martin delivered a positive earnings surprise in last four reported quarter, the average beat being 17.35%. The Zacks Consensus Estimate for 2019 has moved up 5.4% over the past 60 days to $20.53.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>